Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
Terry Cheuk‐Fung Yip, Fei Lyu, Huapeng Lin, et al.
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. Suppl, pp. S171-S183
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Low liver fat in non‐alcoholic steatohepatitis‐related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality
Sung Won Lee, Daniel Q. Huang, Ricki Bettencourt, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 59, Iss. 1, pp. 80-88
Open Access | Times Cited: 16
Metabolomic Hallmarks of Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease
Diren Beyoğlu, Yury Popov, Jeffrey R. Idle
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12809-12809
Open Access | Times Cited: 6
Association between neutrophil-albumin ratio and ultrasound-defined metabolic dysfunction-associated fatty liver disease in U.S. adults: evidence from NHANES 2017–2018
M R He, Xin-jie Du, Yi-ming Liu
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Mitochondrial mt12361A>G increased risk of metabolic dysfunction-associated steatotic liver disease among non-diabetes
Ming‐Ying Lu, Yu‐Ju Wei, Chih‐Wen Wang, et al.
World Journal of Gastroenterology (2025) Vol. 31, Iss. 10
Closed Access
Diagnostic Value of Serum Cytokeratin 18 for the Staging of Liver Inflammation and Fibrosis: A Meta‐Analysis
Jinwen Chen, Jian Hu, J. Zhuang, et al.
Journal of Clinical Laboratory Analysis (2025)
Open Access
Obesity: pathophysiology and therapeutic interventions
Yue Kong, Hong Seuk Yang, Rong Nie, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access
Serum Cytokeratin-18 levels as a prognostic biomarker in advanced liver disease: a comprehensive meta-analysis
Xin Zhang, Jiangguo Li, Jiang Li, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
The Metabolomic Footprint of Liver Fibrosis
Diren Beyoğlu, Yury Popov, Jeffrey R. Idle
Cells (2024) Vol. 13, Iss. 16, pp. 1333-1333
Open Access | Times Cited: 3
Validation of the diagnostic accuracy of the acFibroMASH index for at-risk MASH in patients with metabolic dysfunction-associated steatotic liver disease
Yunfei Wu, Yan Han, Liming Zheng, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Prospective direct comparison of non‐invasive liver tests in outpatients with type 2 diabetes using intention‐to‐diagnose analysis
Thierry Poynard, Olivier Deckmyn, Valentina Peta, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 9, pp. 888-902
Open Access | Times Cited: 6
Evolutive Models, Algorithms and Predictive Parameters for the Progression of Hepatic Steatosis
Marinela Sînziana Tudor, Veronica Gheorman, Georgiana-Mihaela Simeanu, et al.
Metabolites (2024) Vol. 14, Iss. 4, pp. 198-198
Open Access | Times Cited: 2
Advances in Noninvasive Molecular Imaging Probes for Liver Fibrosis Diagnosis
Shaofang Chen, Danping Zhuang, Qingyun Jia, et al.
Biomaterials Research (2024) Vol. 28
Open Access | Times Cited: 2
Editorial: Inflammation and chronic disease
Frank A. Orlando, Arch G. Mainous
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 2
Serum Cytokeratin 18 Fragment is an Indicator for Treating Metabolic Dysfunction-associated Steatotic Liver Disease
Miwa Kawanaka, Yoshihiro Kamada, Kazuhiro Takahashi, et al.
Gastro Hep Advances (2024) Vol. 3, Iss. 8, pp. 1120-1128
Open Access | Times Cited: 2
Structure-function analysis of time-resolved immunological phases in metabolic dysfunction-associated fatty liver disease (MASH) comparing the NIF mouse model to human MASH
Anja Schmidt-Christensen, G. Eriksson, William Michael Laprade, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Machine learning based identification potential feature genes for prediction of drug efficacy in nonalcoholic steatohepatitis animal model
Marwa Matboli, Ibrahim Abdelbaky, Abdelrahman Khaled, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
MASLD: predictive value for liver-related events and extra-hepatic complications
Mohamad Jamalinia, Amedeo Lonardo
Expert Review of Gastroenterology & Hepatology (2024), pp. 1-4
Open Access | Times Cited: 1
Influence of Inula helenium rhizomes and Matricaria chamomilla inflorescences on the biochemical and physiological parameters in male rats fed a high-fat diet
M. A. Lieshchova, Valentyn Yefimov, Victor Brygadyrenko
Roczniki Państwowego Zakładu Higieny (2023), pp. 447-458
Open Access | Times Cited: 3
Baseline Tyrosine Level Is Associated with Dynamic Changes in FAST Score in NAFLD Patients under Lifestyle Modification
Hwi Young Kim, Da Jung Kim, Hye Ah Lee, et al.
Metabolites (2023) Vol. 13, Iss. 3, pp. 444-444
Open Access | Times Cited: 1
Neither hepatic steatosis nor fibrosis is associated with clinical outcomes in patients with intestinal Behçet’s disease
Hye Kyung Hyun, Jihye Park, Soo Jung Park, et al.
European Journal of Gastroenterology & Hepatology (2024) Vol. 36, Iss. 4, pp. 445-451
Closed Access
Structure-function analysis of time-resolved immunological phases in metabolic dysfunction- associated fatty liver disease
Anja Schmidt-Christensen, G. Eriksson, William Michael Laprade, et al.
Research Square (Research Square) (2024)
Open Access
A Systematic review of Inflammatory biomarkers, Clinical significance, Detection, and their therapeutic agents
Varahalarao Vadlapudi, Sandeep Kulkarni
World Journal of Biology Pharmacy and Health Sciences (2024) Vol. 17, Iss. 3, pp. 242-251
Open Access
Chondroitin Sulfate from Halaelurus burgeri Skin Inhibits Hepatic Endoplasmic Reticulum Stress and Inflammation, and Regulates Gut Microbiota
Zhaocai Ren, Shang Gao, Shiwei Hu, et al.
Molecular Nutrition & Food Research (2024)
Closed Access
EXAMES DE IMAGEM NA AVALIAÇÃO DA ESTEATOSE HEPÁTICA
André Matheus Carvalho Silva Leite, Edwardo Arcanjo Silva, Ingrid Gabriela Dorneles Gomes, et al.
Brazilian Journal of Implantology and Health Sciences (2023) Vol. 5, Iss. 4, pp. 744-752
Open Access
Logic-Based Reverse Analysis: A Covid-19 Surveillance Data Set Classification Problem
Hamza Abubakar, Surajo Yusuf
Journal of Basic and Applied Research in Biomedicine (2023) Vol. 9, Iss. 1, pp. 17-25
Open Access
Page 1 - Next Page

Scroll to top